Cetera Investment Advisers
TWST icon

Cetera Investment Advisers’s Twist Bioscience TWST Stock Holding History

Cetera Investment Advisers’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.4M Buy
13,607
+5,771
+74% +$376K ﹤0.01% 2715
2026
Q1 		$372K Sell
7,836
-588
-7% -$26.4K ﹤0.01% 3789
2025
Q4 		$267K Buy
+8,424
New +$263K ﹤0.01% 4004
2025
Q1 		– Sell
-4,727
Closed -$220K – 4071
2024
Q4 		$220K Buy
+4,727
New +$214K ﹤0.01% 3363

Other funds holding TWST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Cetera Investment Advisers's TWST Position: Q2 2026 in Review

Cetera Investment Advisers increased its Twist Bioscience (TWST) stake by 74% in Q2 2026, buying an estimated $376K and bringing the position to 13,607 shares worth $1.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2715.

Cetera Investment Advisers first reported a position in TWST in Q4 2024 and has held it in 4 quarters since. 337 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • Cetera Investment Advisers held 13,607 shares of Twist Bioscience worth $1.4M as of Q2 2026.
  • Cetera Investment Advisers bought 5,771 Twist Bioscience shares in Q2 2026, an estimated $376K.
  • Twist Bioscience made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #2715 holding.
  • Cetera Investment Advisers first reported a position in Twist Bioscience in Q4 2024 and has held it in 4 quarters since.
  • 337 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.